Deep brain stimulation (DBS) at the interface of neurology and psychiatry
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Deep brain stimulation (DBS) is an emerging interventional therapy for well-screened patients with specific treatment-resistant neuropsychiatric diseases. Some neuropsychiatric conditions, such as Parkinson disease, have available and reasonable guideline and efficacy data, while other conditions, such as major depressive disorder and Tourette syndrome, have more limited, but promising results. This review summarizes both the efficacy and the neuroanatomical targets for DBS in four common neuropsychiatric conditions: Parkinson disease, Tourette syndrome, major depressive disorder, and obsessive-compulsive disorder. Based on emerging new research, we summarize novel approaches to optimization of stimulation for each neuropsychiatric disease and we review the potential positive and negative effects that may be observed following DBS. Finally, we summarize the likely future innovations in the field of electrical neural-network modulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 11×
“Four main targets exist for depression DBS: the VC/VS, the sub-callosal cingulate (SCC) (brain area 25 [BA 25]), the NAc, and the medial forebrain bundle (MFB) (28), although the inferior thalamic peduncle (ITP) (85) and lateral habenula (86) are also potentially efficacious DBS targets.”
InfluentialJ Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
Responsive cortical stimulation for the treatment of medically intractable partial epilepsy
Morrell, M. J. (2011) · Neurology · doi:10.1212/wnl.0b013e3182302056 · Cited by 1,282 · cited 1×
“This technology has already become available in epilepsy devices where the electrical signature is better characterized (47).”
Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027 · cited 1×
“Two depression targets, the NAc and the superolateral MFB (slMFB), are central components of the reward system, which has been shown to be dysfunctional in depression (100).”
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder
Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M.-L., Fontaine, D., Montcel, S. T. D., Yelnik, J., Chéreau, I., Arbus, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708514 · Cited by 965
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Rauch, S. L., Rasmussen, S. A., Machado, A. G., Kubu, C. S., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.029 · Cited by 897 · cited 2×
“DBS studies targeting the SCC (21), internal capsule (97), and the reward circuitry (28, 101) have shown efficacy in not only severe unipolar depression, but also in individuals with bipolar disorder that were in an extended depressive episode (88).”
Greenberg, B. D., Gabriels, L. A., Malone, D. A., Rezai, A. R., Friehs, G. M., Okun, M. S., Shapira, N. A., Foote, K. D., Cosyns, P. R., Kubu, C. S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.55 · Cited by 867
Self-citationBewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · cited 2×
“The response and remission rates of NAc are 50% and 30%, respectively, at 12 months (101) and 45% and 9% at two years (102).”
Probing and regulating dysfunctional circuits using deep brain stimulation
Lozano, A. M., & Lipsman, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.020 · Cited by 665
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression
Holtzheimer, P. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1456 · Cited by 608 · cited 2×
“and bipolar depression (88) while appearing not to have the risk of mania seen with other depression targets (89).”
Rapid effects of deep brain stimulation for treatment-resistant major depression
Schlaepfer, T. E., Bewernick, B. H., Kayser, S., Mädler, B., & Coenen, V. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.034 · Cited by 563 · cited 6×
“Four main targets exist for depression DBS: the VC/VS, the sub-callosal cingulate (SCC) (brain area 25 [BA 25]), the NAc, and the medial forebrain bundle (MFB) (28), although the inferior thalamic peduncle (ITP) (85) and lateral habenula (86) are also potentially efficacious DBS targets.”
InfluentialJohansen-Berg, H., Gutman, D. A., Behrens, T. E. J., Matthews, P. M., Rushworth, M. F. S., Katz, E., Lozano, A. M., & Mayberg, H. S. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm167 · Cited by 561
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., Craddock, R. C., & Mayberg, H. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.143 · Cited by 561 · cited 1×
“Depression is a heterogenous disorder that manifests with a variety of symptom constellations arising from several dysfunctional nodes (104) in one or several mood networks that is/are dysfunctional (105).”
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years
Kennedy, S. H., Giacobbe, P., Rizvi, S. J., Placenza, F. M., Nishikawa, Y., Mayberg, H. S., & Lozano, A. M. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10081187 · Cited by 481 · cited 1×
“The long-term response rate for SCC DBS was approximately 60% (94).”
Bewernick, B. H., Kayser, S., Sturm, V., & Schlaepfer, T. E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.44 · Cited by 371 · cited 2×
“The response and remission rates of NAc are 50% and 30%, respectively, at 12 months (101) and 45% and 9% at two years (102).”
Goodman, W. K., Foote, K. D., Greenberg, B. D., Ricciuti, N., Bauer, R., Ward, H., Shapira, N. A., Wu, S. S., Hill, C. L., Rasmussen, S. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.028 · Cited by 362
Self-citationLozano, A. M., Giacobbe, P., Hamani, C., Rizvi, S. J., Kennedy, S. H., Kolivakis, T. T., Debonnel, G., Sadikot, A. F., Lam, R. W., Howard, A. K., et al. (2012) · Journal of Neurosurgery · doi:10.3171/2011.10.jns102122 · Cited by 356
Drevets, W. C., Öngür, D., & Price, J. L. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000370 · Cited by 352
Huff, W., Lenartz, D., Schormann, M., Lee, S.-H., Kuhn, J., Koulousakis, A., Mai, J., Daumann, J., Maarouf, M., Klosterkötter, J., et al. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2009.11.006 · Cited by 315
Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues
Greenberg, B. D., Price, L. H., Rauch, S. L., Friehs, G., Noren, G., Malone, D., Carpenter, L. L., Rezai, A. R., & Rasmussen, S. A. (2003) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(03)00005-6 · Cited by 300 · cited 1×
“There are DBS inclusion and exclusion criteria published for TS (12) and PD (13); however, there are less welldefined guidelines for depression and OCD (14).”
Jiménez, F., Velasco, F., Salin-Pascual, R., Hernández, J. A., Velasco, M., Criales, J. L., & Nicolini, H. (2005) · Neurosurgery · doi:10.1227/01.neu.0000170434.44335.19 · Cited by 291
New targets for rTMS in depression: A review of convergent evidence
Downar, J., & Daskalakis, Z. J. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.08.006 · Cited by 257
Harrison, B. J., Pujol, J., Cardoner, N., Deus, J., Alonso, P., López-Solà, M., Contreras-Rodríguez, O., Real, E., Segalàs, C., Blanco-Hinojo, L., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.006 · Cited by 234 · cited 1×
“In the future, target selection may be guided by a combination of the major symptom dimensions and by neuroanatomical subtypes discovered on detailed neuroimaging (122, 123).”
A tractography analysis of two deep brain stimulation white matter targets for depression
Gutman, D. A., Holtzheimer, P. E., Behrens, T. E. J., Johansen-Berg, H., & Mayberg, H. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.021 · Cited by 220 · cited 1×
“Because of the microstructural variability within an individual’s brain connectivity (33), personalization of therapy will likely occur not only at the level of modifications for specific disease and general affected circuitry (34), but potentially even at the level of an individual’s differences in specific neural co…”
Stefurak, T., Mikulis, D., Mayberg, H., Lang, A. E., Hevenor, S., Pahapill, P., Saint‐Cyr, J., & Lozano, A. (2003) · Movement Disorders · doi:10.1002/mds.10593 · Cited by 215 · cited 3×
“and may be stimulation related (142), resolving when the DBS is turned off (133).”
Deep brain stimulation of nucleus accumbens on heroin-seeking behaviors: a case report
Zhou, H., Xu, J., & Jiang, J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.012 · Cited by 148
Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction
Kuhn, J., Möller, M., Treppmann, J. F., Bartsch, C., Lenartz, D., Gruendler, T. O. J., Maarouf, M., Brosig, A., Barnikol, U. B., Klosterkötter, J., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.196 · Cited by 147
Bourne, S. K., Eckhardt, C. A., Sheth, S. A., & Eskandar, E. N. (2012) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2012.00029 · Cited by 146
Okun, M. S., Bowers, D., Springer, U., Shapira, N. A., Malone, D., Rezai, A. R., Nuttin, B., Heilman, K. M., Morecraft, R. J., Rasmussen, S. A., et al. (2004) · Neurocase · doi:10.1080/13554790490507632 · Cited by 123 · cited 1×
“the ventral capsule/ventral striatum (VC/VS) (22).”
Self-citationRamasubbu, R., Anderson, S., Haffenden, A., Chavda, S., & Kiss, Z. H. T. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120160 · Cited by 101 · cited 2×
“It is also clear that efficacy will increase when programming settings (96), the lead position in relation to the relevant circuitry (106), and the exact microstructural targets of modulation (93) are optimized.”
Tractography-activation models applied to subcallosal cingulate deep brain stimulation
Lujan, J. L., Chaturvedi, A., Choi, K. S., Holtzheimer, P. E., Gross, R. E., Mayberg, H. S., & McIntyre, C. C. (2013) · Brain stimulation · doi:10.1016/j.brs.2013.03.008 · Cited by 101 · cited 1×
“It is also clear that efficacy will increase when programming settings (96), the lead position in relation to the relevant circuitry (106), and the exact microstructural targets of modulation (93) are optimized.”
Relapse rates with long‐term antidepressant drug therapy: a meta‐analysis
Williams, N., Simpson, A. N., Simpson, K., & Nahas, Z. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1033 · Cited by 74
Self-citation
Cited by
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
Cole, E. J., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., Nejad, R., Pankow, H., Choi, E., Aaron, H., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070720 · Cited by 802
Self-citationPeters, S. K., Dunlop, K., & Downar, J. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00104 · Cited by 611
“However, more recently, DBS has begun to show promise as a treatment for a number of neuropsychiatric disorders (Williams and Okun, 2013), including MDD (Mayberg et al.”
BackgroundRefining deep brain stimulation to emulate optogenetic treatment of synaptic pathology
Creed, M., Pascoli, V. J., & Lüscher, C. (2015) · Science · doi:10.1126/science.1260776 · Cited by 280
Lewis, P. M., Ackland, H. M., Lowery, A. J., & Rosenfeld, J. V. (2015) · Brain Research · doi:10.1016/j.brainres.2014.11.020 · Cited by 228
Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant.
Folcher, M., Oesterle, S., Zwicky, K., Thekkottil, T., Heymoz, J., Hohmann, M., Christen, M., Daoud El-Baba, M., Buchmann, P., & Fussenegger, M. (2014) · Nature Communications · doi:10.1038/ncomms6392 · Cited by 130
Metadata
- Authors
- Williams, N. R., & Okun, M. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-11-01
- Volume
- 123
- Issue
- 11
- Pages
- 4546-4556
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2070414981
- Cited by
- 128
- References
- 32
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.